Sr One Capital Management, Llc
10% Owner at ADARx Pharmaceuticals, Inc. (ADRX); 10% Owner at Zenas BioPharma, Inc. (ZBIO)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-23.5%
vs. S&P 500-28.8%
Beat the market0%
Paper profit on buys+$2.3M
Total bought / sold$29.6M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 29SEC | ADRXADARx Pharmaceuticals, Inc. | Buy | 592,5935,554,094 held (+12%) | $17.00 | $10.1M | +4.6% |
| Sep 29SEC | ADRXADARx Pharmaceuticals, Inc. | Buy | 414,8141,953,505 held (+27%) | $17.00 | $7.1M | +4.6% |
| Sep 29SEC | ADRXADARx Pharmaceuticals, Inc. | Buy | 592,593new position | $17.00 | $10.1M | +4.6% |
| Oct 14SEC | ZBIOZenas BioPharma, Inc. | Buy | 63,1581,173,395 held (+6%) | $19.00 | $1.2M | +43.5% |
| Oct 14SEC | ZBIOZenas BioPharma, Inc. | Buy | 63,1571,917,895 held (+3%) | $19.00 | $1.2M | +43.5% |
- Buy
10% Owner Sr One Capital Management, Llc bought $10.1M of ADRX at $17.00 — first open-market purchase in our records.
- Buy
10% Owner Sr One Capital Management, Llc bought $7.1M of ADRX at $17.00 — raises the stake by 27%.
- Buy
10% Owner Sr One Capital Management, Llc bought $10.1M of ADRX at $17.00 — opens a new position.
- Buy
10% Owner Sr One Capital Management, Llc bought $1.2M of ZBIO at $19.00 — first open-market purchase in our records.